tiprankstipranks
Lantheus Holdings Inc (DE:0L8)
NASDAQ:0L8
Germany Market
0L8
Lantheus
RESEARCH TOOLSreports

Lantheus (0L8) Stock Forecast & Price Target

7 Followers
See the Price Targets and Ratings of:

0L8 Analyst Ratings

Hold
10Ratings
Hold
2 Buy
7 Hold
1 Sell
Based on 10 analysts giving stock ratings to
Lantheus
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0L8 Stock 12 Month Forecast

Average Price Target

€94.08
▼(-0.34% Downside)
Based on 10 Wall Street analysts offering 12 month price targets for Lantheus in the last 3 months. The average price target is €94.08 with a high forecast of €111.58 and a low forecast of €88.66. The average price target represents a -0.34% change from the last price of €94.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"41":"€41","112":"€112","58.75":"€58.8","76.5":"€76.5","94.25":"€94.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":111.57856806000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€111.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":94.08186237085715,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€94.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":88.65738935,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€88.66</span>\n  </div></div>","useHTML":true}}],"tickPositions":[41,58.75,76.5,94.25,112],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,87,88.89065908153846,90.78131816307692,92.67197724461539,94.56263632615385,96.45329540769231,98.34395448923077,100.23461357076924,102.1252726523077,104.01593173384616,105.90659081538462,107.79724989692309,109.68790897846155,{"y":111.57856806000001,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,87,87.54475864391209,88.08951728782418,88.63427593173627,89.17903457564836,89.72379321956045,90.26855186347254,90.81331050738461,91.3580691512967,91.9028277952088,92.44758643912088,92.99234508303297,93.53710372694506,{"y":94.08186237085715,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,87,87.12749148846154,87.25498297692307,87.38247446538462,87.50996595384615,87.63745744230769,87.76494893076924,87.89244041923077,88.01993190769231,88.14742339615385,88.27491488461538,88.40240637307693,88.52989786153846,{"y":88.65738935,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":61.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.76,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.98,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.53,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.82,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.52,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.36,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.24,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.2,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€111.58Average Price Target€94.08Lowest Price Target€88.66
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on DE:0L8
Andy Hsieh
William Blair
William Blair
―
Hold
―
Reiterated
08/08/26
Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (NASDAQ: LXRX), Ascendis Pharma (NASDAQ: ASND) and Lantheus (NASDAQ: LNTH)
Truist Financial Analyst forecast on DE:0L8
Richard Newitter
Truist Financial
Truist Financial
€108.12→€88.66
Hold
-6.08%
Downside
Downgraded
08/04/26
Analysts Offer Insights on Healthcare Companies: Oculis Holding (NASDAQ: OCS) and Lantheus (NASDAQ: LNTH)
CJS Securities Analyst forecast on DE:0L8
Lawrence Solow
CJS Securities
CJS Securities
―
Hold
―
Downgraded
08/04/26
Lantheus downgraded to Market Perform from Outperform at CJS SecuritiesLantheus downgraded to Market Perform from Outperform at CJS Securities
TD Cowen Analyst forecast on DE:0L8
Tara Bancroft
TD Cowen
TD Cowen
€95.14→€88.66
Hold
-6.08%
Downside
Downgraded
08/03/26
Lantheus downgraded to Hold from Buy at TD CowenLantheus downgraded to Hold from Buy at TD Cowen
JonesTrading Analyst forecast on DE:0L8
Justin Walsh
JonesTrading
JonesTrading
―
Hold
―
Reiterated
08/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (NASDAQ: AUTL) and Lantheus (NASDAQ: LNTH)
Leerink Partners Analyst forecast on DE:0L8
Roanna Ruiz
Leerink Partners
Leerink Partners
€88.66
Hold
-6.08%
Downside
Downgraded
08/03/26
Lantheus downgraded to Market Perform from Outperform at LeerinkLantheus downgraded to Market Perform from Outperform at Leerink
B. Riley Securities Analyst forecast on DE:0L8
Yuan Zhi
B. Riley Securities
B. Riley Securities
€83.9→€111.58
Buy
18.20%
Upside
Reiterated
07/29/26
Lantheus price target raised to $129 from $97 at B. RileyLantheus price target raised to $129 from $97 at B. Riley
Mizuho Securities Analyst forecast on DE:0L8
Anthony Petrone
Mizuho Securities
Mizuho Securities
€103.79→€99.47
Buy
5.37%
Upside
Reiterated
07/29/26
Lantheus price target lowered to $115 from $120 at MizuhoLantheus price target lowered to $115 from $120 at Mizuho
Brookline Capital Markets Analyst forecast on DE:0L8
Kemp Dolliver
Brookline Capital Markets
Brookline Capital Markets
€90.82
Hold
-3.79%
Downside
Downgraded
07/28/26
Lantheus downgraded to Hold from Buy at BrooklineLantheus downgraded to Hold from Buy at Brookline
Baptista Research Analyst forecast on DE:0L8
Unknown Analyst
Baptista Research
Not Ranked
Baptista Research
€90.73
Sell
-3.88%
Downside
Initiated
06/16/26
Lantheus (LNTH) Gets a Sell from Baptista Research
Citizens JMP Analyst forecast on DE:0L8
David Turkaly
Citizens JMP
Citizens JMP
€73.52→€99.47
Buy
5.37%
Upside
Reiterated
05/08/26
Lantheus price target raised to $115 from $85 at CitizensLantheus price target raised to $115 from $85 at Citizens
Goldman Sachs Analyst forecast on DE:0L8
Paul Choi
Goldman Sachs
Goldman Sachs
€70.93→€81.31
Hold
-13.87%
Downside
Reiterated
05/07/26
Lantheus price target raised to $94 from $82 at Goldman SachsLantheus price target raised to $94 from $82 at Goldman Sachs
Jefferies Analyst forecast on DE:0L8
Matthew Taylor
Jefferies
Jefferies
€95.14
Buy
0.79%
Upside
Reiterated
03/18/26
Lantheus price target raised to $110 from $105 at JefferiesLantheus price target raised to $110 from $105 at Jefferies
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on DE:0L8
Andy Hsieh
William Blair
William Blair
―
Hold
―
Reiterated
08/08/26
Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (NASDAQ: LXRX), Ascendis Pharma (NASDAQ: ASND) and Lantheus (NASDAQ: LNTH)
Truist Financial Analyst forecast on DE:0L8
Richard Newitter
Truist Financial
Truist Financial
€108.12→€88.66
Hold
-6.08%
Downside
Downgraded
08/04/26
Analysts Offer Insights on Healthcare Companies: Oculis Holding (NASDAQ: OCS) and Lantheus (NASDAQ: LNTH)
CJS Securities Analyst forecast on DE:0L8
Lawrence Solow
CJS Securities
CJS Securities
―
Hold
―
Downgraded
08/04/26
Lantheus downgraded to Market Perform from Outperform at CJS SecuritiesLantheus downgraded to Market Perform from Outperform at CJS Securities
TD Cowen Analyst forecast on DE:0L8
Tara Bancroft
TD Cowen
TD Cowen
€95.14→€88.66
Hold
-6.08%
Downside
Downgraded
08/03/26
Lantheus downgraded to Hold from Buy at TD CowenLantheus downgraded to Hold from Buy at TD Cowen
JonesTrading Analyst forecast on DE:0L8
Justin Walsh
JonesTrading
JonesTrading
―
Hold
―
Reiterated
08/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (NASDAQ: AUTL) and Lantheus (NASDAQ: LNTH)
Leerink Partners Analyst forecast on DE:0L8
Roanna Ruiz
Leerink Partners
Leerink Partners
€88.66
Hold
-6.08%
Downside
Downgraded
08/03/26
Lantheus downgraded to Market Perform from Outperform at LeerinkLantheus downgraded to Market Perform from Outperform at Leerink
B. Riley Securities Analyst forecast on DE:0L8
Yuan Zhi
B. Riley Securities
B. Riley Securities
€83.9→€111.58
Buy
18.20%
Upside
Reiterated
07/29/26
Lantheus price target raised to $129 from $97 at B. RileyLantheus price target raised to $129 from $97 at B. Riley
Mizuho Securities Analyst forecast on DE:0L8
Anthony Petrone
Mizuho Securities
Mizuho Securities
€103.79→€99.47
Buy
5.37%
Upside
Reiterated
07/29/26
Lantheus price target lowered to $115 from $120 at MizuhoLantheus price target lowered to $115 from $120 at Mizuho
Brookline Capital Markets Analyst forecast on DE:0L8
Kemp Dolliver
Brookline Capital Markets
Brookline Capital Markets
€90.82
Hold
-3.79%
Downside
Downgraded
07/28/26
Lantheus downgraded to Hold from Buy at BrooklineLantheus downgraded to Hold from Buy at Brookline
Baptista Research Analyst forecast on DE:0L8
Unknown Analyst
Baptista Research
Not Ranked
Baptista Research
€90.73
Sell
-3.88%
Downside
Initiated
06/16/26
Lantheus (LNTH) Gets a Sell from Baptista Research
Citizens JMP Analyst forecast on DE:0L8
David Turkaly
Citizens JMP
Citizens JMP
€73.52→€99.47
Buy
5.37%
Upside
Reiterated
05/08/26
Lantheus price target raised to $115 from $85 at CitizensLantheus price target raised to $115 from $85 at Citizens
Goldman Sachs Analyst forecast on DE:0L8
Paul Choi
Goldman Sachs
Goldman Sachs
€70.93→€81.31
Hold
-13.87%
Downside
Reiterated
05/07/26
Lantheus price target raised to $94 from $82 at Goldman SachsLantheus price target raised to $94 from $82 at Goldman Sachs
Jefferies Analyst forecast on DE:0L8
Matthew Taylor
Jefferies
Jefferies
€95.14
Buy
0.79%
Upside
Reiterated
03/18/26
Lantheus price target raised to $110 from $105 at JefferiesLantheus price target raised to $110 from $105 at Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lantheus

3 Months
David TurkalyCitizens JMP
Success Rate
11/19 ratings generated profit
58%
Average Return
+2.19%
Copying David Turkaly's trades and holding each position for 3 Months would result in 57.89% of your transactions generating a profit, with an average return of +2.19% per trade.
1 Year
Anthony PetroneMizuho Securities
Success Rate
18/27 ratings generated profit
67%
Average Return
+22.61%
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +22.61% per trade.
2 Years
Yuan ZhiB. Riley Securities
Success Rate
16/20 ratings generated profit
80%
Average Return
+28.77%
Copying Yuan Zhi's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +28.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0L8 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
14
17
14
18
10
Hold
1
2
2
3
8
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
15
19
17
22
19
In the current month, 0L8 has received 10 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. 0L8 average Analyst price target in the past 3 months is 94.08.
Each month's total comprises the sum of three months' worth of ratings.

0L8 Financial Forecast

0L8 Earnings Forecast

Next quarter’s earnings estimate for 0L8 is €1.11 with a range of €1.01 to €1.27. The previous quarter’s EPS was €1.35. 0L8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 42.68% of the time in the same period. In the last calendar year 0L8 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0L8 is €1.11 with a range of €1.01 to €1.27. The previous quarter’s EPS was €1.35. 0L8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 42.68% of the time in the same period. In the last calendar year 0L8 has Performed in-line its overall industry.

0L8 Sales Forecast

Next quarter’s sales forecast for 0L8 is €311.71M with a range of €299.77M to €342.55M. The previous quarter’s sales results were €336.89M. 0L8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.84% of the time in the same period. In the last calendar year 0L8 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0L8 is €311.71M with a range of €299.77M to €342.55M. The previous quarter’s sales results were €336.89M. 0L8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.84% of the time in the same period. In the last calendar year 0L8 has Performed in-line its overall industry.

0L8 Stock Forecast FAQ

What is DE:0L8’s average 12-month price target, according to analysts?
Based on analyst ratings, Lantheus Holdings Inc’s 12-month average price target is 94.08.
    What is DE:0L8’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:0L8, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Lantheus Holdings Inc a Buy, Sell or Hold?
        Lantheus Holdings Inc has a consensus rating of Hold, which is based on 2 buy ratings, 7 hold ratings and 1 sell ratings.
          What is Lantheus Holdings Inc’s share price target?
          The average share price target for Lantheus Holdings Inc is 94.08. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €111.58 ,and the lowest forecast is €88.66. The average share price target represents -0.34% Decrease from the current price of €94.4.
            What do analysts say about Lantheus Holdings Inc?
            Lantheus Holdings Inc’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Lantheus Holdings Inc?
              To buy shares of DE:0L8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.